⌘+K

Pulse Explore Communities Researchers Journals

Browser extensionInstagram

Home Communities Explore

March 13, 2024JAMA

CDC Recommends Additional COVID-19 Booster for Older Adults

Samantha Anderer

View at Publisher

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

From October 2023 to December 2023, older adults made up more than half of COVID-19 hospitalizations in the US. The Centers for Disease Control and Prevention (CDC) now recommends an additional updated 2023-2024 COVID-19 vaccine dose for adults aged 65 years or older.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Samantha Anderer (2024) studied this question.

synapsesocial.com/papers/68e74345b6db6435876bc729 https://doi.org/10.1001/jama.2024.2071

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Use of an Additional Updated 2023–2024 COVID-19 Vaccine Dose for Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 20242024 · 29 citations
2COVID-19 Vaccine Booster: To Boost or Not to BoostOriginal Research · 2021 · 108 citations
3Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults — United States, September 22, 2021–February 6, 2022cohort · 2022 · 98 citations
4COVID-19–Associated Hospitalizations Among U.S. Adults Aged ≥18 Years — COVID-NET, 12 States, October 2023–April 20242024 · 33 citations
5Safety Monitoring of COVID-19 mRNA Vaccine Second Booster Doses Among Adults Aged ≥50 Years — United States, March 29, 2022–July 10, 2022cohort · 2022 · 30 citations
6Use of COVID-19 Vaccines for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024–20252024 · 85 citations
7Use of Updated COVID-19 Vaccines 2023–2024 Formula for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2023Review · 2023 · 144 citations
8Interim Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19–Associated Hospitalization Among Adults Aged ≥18 Years with Immunocompromising Conditions — VISION Network, September 2023–February 20242024 · 37 citations
9JamaJAMA · 2026
10Think Outside the Box With Intravenous Iron—The New Ferric Carboxymaltose FDA Boxed WarningJAMA · 2026